Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

1(14%)

Results Posted

25%(1 trials)

Terminated

2(29%)

Phase Distribution

Ph phase_1

29%

Ph not_applicable

14%

Ph phase_3

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 1Safety & dosage

2(33.3%)

Phase 3Large-scale testing

3(50.0%)

N/ANon-phased studies

1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(2)

Detailed Status

Completed4

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (33.3%)

Phase 33 (50.0%)

N/A1 (16.7%)

Trials by Status

recruiting114%

completed457%

terminated229%

Recent Activity

1 active trials

Showing 5 of 7

recruitingphase_3

Avoiding Anticoagulation After IntraCerebral Haemorrhage

NCT03243175

completedphase_3

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

NCT03692065

completed

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

NCT04477837

terminatednot_applicable

Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

NCT03136510

terminatedphase_3

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

NCT04142658

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03243175Phase 3

Avoiding Anticoagulation After IntraCerebral Haemorrhage

Recruiting

NCT03692065Phase 3

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Completed

NCT04477837

Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants

Completed

NCT03136510Not Applicable

Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban

Terminated

NCT04142658Phase 3

PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban

Terminated

NCT04278729Phase 1

A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome

Completed

NCT03083704Phase 1

A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa

Completed

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7